» Articles » PMID: 29089343

Impact of Atrial Fibrillation on Exercise Capacity and Mortality in Heart Failure With Preserved Ejection Fraction: Insights From Cardiopulmonary Stress Testing

Overview
Date 2017 Nov 2
PMID 29089343
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Atrial fibrillation (AF) has been objectively associated with exercise intolerance in patients with heart failure with reduced ejection fraction; however, its impact in patients with heart failure with preserved ejection fraction has not been fully scrutinized.

Methods And Results: We identified 1744 patients with heart failure and ejection fraction ≥50% referred for cardiopulmonary stress testing at the Cleveland Clinic (Cleveland, OH), 239 of whom had AF. We used inverse probability of treatment weighting to balance clinical characteristics between patients with and without AF. A weighted linear regression model, adjusted for unbalanced variables (age, sex, diagnosis, hypertension, and β-blocker use), was used to compare metabolic stress parameters and 8-year total mortality (social security index) between both groups. Weighted mean ejection fraction was 58±5.9% in the entire population. After adjusting for unbalanced weighted variables, patients with AF versus those without AF had lower mean peak oxygen consumption (18.5±6.2 versus 20.3±7.1 mL/kg per minute), oxygen pulse (12.4±4.3 versus 12.9±4.7 mL/beat), and circulatory power (2877±1402 versus 3351±1788 mm Hg·mL/kg per minute) (<0.001 for all comparisons) but similar submaximal exercise capacity (oxygen consumption at anaerobic threshold, 12.0±5.1 versus 12.4±6.0mL/kg per minute; =0.3). Both groups had similar peak heart rate, whereas mean peak systolic blood pressure was lower in the AF group (150±35 versus 160±51 mm Hg; <0.001). Moreover, AF was associated with higher total mortality.

Conclusions: In the largest study of its kind, we demonstrate that AF is associated with peak exercise intolerance, impaired contractile reserve, and increased mortality in patients with heart failure with preserved ejection fraction. Whether AF is the primary offender in these patients or merely a bystander to worse diastolic function requires further investigation.

Citing Articles

Mechanisms of exercise intolerance in hear-t failure with preserved ejection fraction (HFpEF).

Pecchia B, Samuel R, Shah V, Newman E, Gibson G Heart Fail Rev. 2025; .

PMID: 40080287 DOI: 10.1007/s10741-025-10504-3.


The impact of atrial fibrillation on oxygen uptake and haemodynamics in patients with heart failure: a systematic review and meta-analysis.

Schmid V, Foulkes S, Dziano J, Wang J, Verwerft J, Elliott A Eur Heart J Open. 2025; 5(1):oeaf003.

PMID: 39949421 PMC: 11823826. DOI: 10.1093/ehjopen/oeaf003.


Different effects of catheter ablation on exercise tolerance, leg strength, and quality of life in paroxysmal versus persistent atrial fibrillation.

Matsuura G, Fukaya H, Hamazaki N, Saito D, Nakamura H, Ishizue N J Arrhythm. 2025; 41(1):e13220.

PMID: 39816996 PMC: 11730720. DOI: 10.1002/joa3.13220.


Atrial Fibrillation Status and Physical Rehabilitation in Older Patients With Acute Decompensated Heart Failure: An Analysis From the REHAB-HF Trial.

Corsi D, Dikdan S, Upadhyay N, Chen H, Kitzman D, Mentz R J Am Heart Assoc. 2024; 13(19):e034366.

PMID: 39291487 PMC: 11681436. DOI: 10.1161/JAHA.124.034366.


Atrial Fibrillation in Endurance Training Athletes: Scoping Review.

Lobo H, Naves I, Marcal S, Canzi C, Rodrigues A, Menezes Jr A Rev Cardiovasc Med. 2024; 24(6):155.

PMID: 39077536 PMC: 11264108. DOI: 10.31083/j.rcm2406155.


References
1.
Al Halabi S, Qintar M, Hussein A, Alraies M, Jones D, Wong T . Catheter Ablation for Atrial Fibrillation in Heart Failure Patients: A Meta-Analysis of Randomized Controlled Trials. JACC Clin Electrophysiol. 2015; 1(3):200-209. PMC: 4525704. DOI: 10.1016/j.jacep.2015.02.018. View

2.
Guazzi M, Belletti S, Bianco E, Lenatti L, Guazzi M . Endothelial dysfunction and exercise performance in lone atrial fibrillation or associated with hypertension or diabetes: different results with cardioversion. Am J Physiol Heart Circ Physiol. 2006; 291(2):H921-8. DOI: 10.1152/ajpheart.00986.2005. View

3.
Atwood J, Myers J, Tang X, Reda D, Singh S, Singh B . Exercise capacity in atrial fibrillation: a substudy of the Sotalol-Amiodarone Atrial Fibrillation Efficacy Trial (SAFE-T). Am Heart J. 2007; 153(4):566-72. DOI: 10.1016/j.ahj.2006.12.020. View

4.
January C, Samuel Wann L, Alpert J, Calkins H, Cigarroa J, Cleveland Jr J . 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014; 64(21):e1-76. DOI: 10.1016/j.jacc.2014.03.022. View

5.
Lok N, Lau C . Oxygen uptake kinetics and cardiopulmonary performance in lone atrial fibrillation and the effects of sotalol. Chest. 1997; 111(4):934-40. DOI: 10.1378/chest.111.4.934. View